Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F69EB14F.svg?ark=w1%2F20260515%2FF69EB14F)](https://nobleid.org/work/w1/20260515/F69EB14F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors